Mounjaro (tirzepatide) 12.5 mg is a treatment for type 2 diabetes, combining GIP and GLP-1 receptor agonist actions. It improves blood sugar control by increasing insulin secretion, lowering glucose production, and slowing gastric emptying. This dual-action approach helps manage blood sugar levels effectively in adults with type 2 diabetes.
For more information - https://www.elliepharma.com/pr....oduct-page/mounjaro-
Like
Comment
Share
